603 related articles for article (PubMed ID: 18405005)
1. [Discovery of the splicing of peptides by the proteasome and study of preclinical models of anticancer immunotherapy].
Van den Eynde B
Bull Mem Acad R Med Belg; 2007; 162(5-6):352-6. PubMed ID: 18405005
[TBL] [Abstract][Full Text] [Related]
2. Development of optimized cryptic peptides for immunotherapy.
Menez-Jamet J; Kosmatopoulos K
IDrugs; 2009 Feb; 12(2):98-102. PubMed ID: 19204883
[TBL] [Abstract][Full Text] [Related]
3. [Identification of cancer antigens of relevance for specific cancer immunotherapy].
van den Eynde B
Bull Mem Acad R Med Belg; 2001; 156(10-12):548-55. PubMed ID: 12371273
[TBL] [Abstract][Full Text] [Related]
4. Overview of tumor cell-based vaccines.
Copier J; Dalgleish A
Int Rev Immunol; 2006; 25(5-6):297-319. PubMed ID: 17169778
[TBL] [Abstract][Full Text] [Related]
5. New frontiers in cell-based immunotherapy of cancer.
D'Elios MM; Del Prete G; Amedei A
Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938
[TBL] [Abstract][Full Text] [Related]
6. Processing and presentation of tumor antigens and vaccination strategies.
van der Bruggen P; Van den Eynde BJ
Curr Opin Immunol; 2006 Feb; 18(1):98-104. PubMed ID: 16343880
[TBL] [Abstract][Full Text] [Related]
7. [General principles and first clinical trials of therapeutic vaccines against cancer].
Baurain JF; Van der Bruggen P; Van den Eynde BJ; Coulie PG; Van Baren N
Bull Cancer; 2008 Mar; 95(3):327-35. PubMed ID: 18390413
[TBL] [Abstract][Full Text] [Related]
8. Combination strategies for enhancing the efficacy of immunotherapy in cancer patients.
Moschella F; Proietti E; Capone I; Belardelli F
Ann N Y Acad Sci; 2010 Apr; 1194():169-78. PubMed ID: 20536466
[TBL] [Abstract][Full Text] [Related]
9. Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity.
Speiser DE; Romero P
Semin Immunol; 2010 Jun; 22(3):144-54. PubMed ID: 20413326
[TBL] [Abstract][Full Text] [Related]
10. Cancer immunotherapy targeting the telomerase reverse transcriptase.
Huo LF; Tang JW; Huang JJ; Huang PT; Huang CF; Kung HF; Lin MC
Cell Mol Immunol; 2006 Feb; 3(1):1-11. PubMed ID: 16549043
[TBL] [Abstract][Full Text] [Related]
11. Cancer vaccines: preclinical studies and novel strategies.
Palena C; Abrams SI; Schlom J; Hodge JW
Adv Cancer Res; 2006; 95():115-45. PubMed ID: 16860657
[TBL] [Abstract][Full Text] [Related]
12. Getting to the surface: a link between tumor antigen discovery and natural presentation of peptide-MHC complexes.
Clark CE; Vonderheide RH
Clin Cancer Res; 2005 Aug; 11(15):5333-6. PubMed ID: 16061844
[No Abstract] [Full Text] [Related]
13. Progress in human tumour immunology and immunotherapy.
Rosenberg SA
Nature; 2001 May; 411(6835):380-4. PubMed ID: 11357146
[TBL] [Abstract][Full Text] [Related]
14. [Immune therapy against tumors based on the ubiquitin-proteasome pathway].
Himeno K; Hisaeda H
Fukuoka Igaku Zasshi; 2007 Aug; 98(8):312-9. PubMed ID: 17907447
[No Abstract] [Full Text] [Related]
15. Antigens for cancer immunotherapy.
Neller MA; López JA; Schmidt CW
Semin Immunol; 2008 Oct; 20(5):286-95. PubMed ID: 18951039
[TBL] [Abstract][Full Text] [Related]
16. Effects of the tumor microenvironment on the efficacy of tumor immunotherapy.
Neeson P; Paterson Y
Immunol Invest; 2006; 35(3-4):359-94. PubMed ID: 16916758
[TBL] [Abstract][Full Text] [Related]
17. Cancer vaccines. Any future?
Myc LA; Gamian A; Myc A
Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):249-59. PubMed ID: 21644030
[TBL] [Abstract][Full Text] [Related]
18. Mini-review: overcoming tumor-intrinsic resistance to immune effector function.
Ganss R; Arnold B; Hämmerling GJ
Eur J Immunol; 2004 Oct; 34(10):2635-41. PubMed ID: 15368278
[TBL] [Abstract][Full Text] [Related]
19. The cyclins: a family of widely expressed tumor antigens?
von Bergwelt-Baildon MS; Kondo E; Klein-González N; Wendtner CM
Expert Rev Vaccines; 2011 Mar; 10(3):389-95. PubMed ID: 21434806
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific antigens and immunologic adjuvants in cancer immunotherapy.
Seremet T; Brasseur F; Coulie PG
Cancer J; 2011; 17(5):325-30. PubMed ID: 21952282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
